Myocarditis and pericarditis associated with SARS-CoV-2 vaccines: A population-based descriptive cohort and a nested self-controlled risk interval study using electronic health care data from four European countries

Article

Abstract: Background: Estimates of the association between COVID-19 vaccines and myo-/pericarditis risk vary w

Palabras claves:

adverse drug reaction, COVID-19 Vaccine, myocarditis , Pericarditis, pharmacovigilance

Autores:

Alsina E., Aragón M., Belitser S.V., Bots S.H., Carlos E. Durán, Douglas I.J., García-Poza P., Gini R., Herings R.M.C., Huerta C., Klungel O.H., Martin I., Martín-Pérez M., Messina D., Overbeek J.A., Pallejà-Millán M., Paoletti O., Riera-Arnau J., Schultze A., Sisay M.M., Souverein P., Sturkenboom M.C.J.M., Swart K.M.A., Villalobos F.

Fuentes:

scopus